Phase II study of preoperative bevacizumab in combination with capecitabine and radiotherapy in patients with locally advanced resectable colorectal cancer.

Trial Profile

Phase II study of preoperative bevacizumab in combination with capecitabine and radiotherapy in patients with locally advanced resectable colorectal cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Capecitabine
  • Indications Adenocarcinoma; Rectal cancer
  • Focus Therapeutic Use
  • Acronyms XEBERECTO
  • Most Recent Events

    • 21 Feb 2015 Status changed from active, no longer recruiting to completed as per European Clinical Trials Database record.
    • 02 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top